Inventor · disambiguated record
Natalie A. Hawryluk
Also filed as: HAWRYLUK NATALIE · HAWRYLUK NATALIE A · HAWRYLUK NATALIE ANNE
26 granted patents·10 pending applications·37 citations·filing 2007–2025
94Inventor score
Files withCELGENE CORP12JANSSEN PHARMACEUTICA NV12EDGEWISE THERAPEUTICS INC4BREITENBUCHER J GUY3APODACA RICHARD2
Top patents by PatentIndex Score
36 records- 0193US11505548B2Heterocyclic compounds and their use for treatment of helminthic infections and diseasesCELGENE CORP·Filed 2020·Granted Nov 22, 2022·4 cites·23 claims
- 0286US9079866B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 14, 2015·8 cites·7 claims
- 0385US9073876B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 7, 2015·6 cites·7 claims
- 0480US8598356B2Heteroaryl-substituted urea modulators of fatty acid amide hydrolaseBREITENBUCHER J GUY·Filed 2009·Granted Dec 3, 2013·4 cites·17 claims
- 0579US8461159B2Heteroaryl-substituted urea modulators of fatty acid amide hydrolaseBREITENBUCHER J GUY·Filed 2009·Granted Jun 11, 2013·4 cites·24 claims
- 0678US10016436B2Animal and human anti-malarial agentsCELGENE CORP·Filed 2017·Granted Jul 10, 2018·2 cites·21 claims
- 0775US12338235B2Heterocyclic compounds and their use for treatment of helminthic infections and diseasesCELGENE CORP·Filed 2022·Granted Jun 24, 2025·0 cites·34 claims
- 0875US2025276967A1Heterocyclic compounds and their use for treatment of helminthic infections and diseasesCELGENE CORP·Filed 2025·Application pending·0 cites
- 0974US10420771B2Animal and human anti-malarial agentsCELGENE CORP·Filed 2018·Granted Sep 24, 2019·1 cites·22 claims
- 1073US8901111B2Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolaseBREITENBUCHER J GUY·Filed 2010·Granted Dec 2, 2014·3 cites·15 claims
- 1172US12448369B2Quinolinone amide compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2024·Granted Oct 21, 2025·0 cites·56 claims
- 1272US9926333B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Mar 27, 2018·1 cites·8 claims
- 1372US9732093B2FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 15, 2017·1 cites·18 claims
- 1471US9884878B2FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Feb 6, 2018·1 cites·6 claims
- 1571US9745328B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 29, 2017·1 cites·16 claims
- 1670US12509431B21,4-dihydroquinazolinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2024·Granted Dec 30, 2025·0 cites·30 claims
- 1766US11344554B2Animal and human anti-malarial agentsCELGENE CORP·Filed 2020·Granted May 31, 2022·0 cites·3 claims
- 1864US10736899B2Animal and human anti-malarial agentsCELGENE CORP·Filed 2019·Granted Aug 11, 2020·0 cites·3 claims
- 1964US2024336609A1Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2060US10047101B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Aug 14, 2018·0 cites·5 claims
- 2160US8906914B2Ethylene diamine modulators of fatty acid hydrolaseHAWRYLUK NATALIE A·Filed 2010·Granted Dec 9, 2014·1 cites·16 claims
- 2260US2025361213A11,4-dihydroquinazolinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2358US9422293B2Tetrahydro-pyrimidoazepines as modulators of TRPV1JANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 23, 2016·0 cites·10 claims
- 2457US8673895B2Tetrahydro-pyrimidoazepines as modulators of TRPV1BRANSTETTER BRYAN JAMES·Filed 2007·Granted Mar 18, 2014·0 cites·12 claims
- 2557US2024148744A1Sulfonamides and their use for treatment of helminthic infections and diseasesCELGENE CORP·Filed 2022·Application pending·0 cites
- 2655US2024025891A1Heterocyclic compounds and their use for treatment of helminthic infections and diseasesCELGENE CORP·Filed 2021·Application pending·0 cites
- 2755US2014066412A1Heteroaryl substituted urea modulators of fatty acid amide hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2013·Application pending·0 cites
- 2855US2024124444A1Heterocyclic Compounds and Their Use for Parasitic DiseasesCELGENE CORP·Filed 2021·Application pending·0 cites
- 2955US2014221322A1Heteroaryl substituted urea modulators of fatty acid amide hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2013·Application pending·0 cites
- 3051US9738649B2Tetrahydro-pyrimidoazepines as modulators of TRPV1JANSSEN PHARMACEUTICA NV·Filed 2016·Granted Aug 22, 2017·0 cites·5 claims
- 3150US10420772B2Animal and human anti-trypanosomonal and anti-leishmania agentsCELGENE CORP·Filed 2018·Granted Sep 24, 2019·0 cites·35 claims
- 3249US8877769B2Heteroaryl-substituted urea modulators of fatty acid amide hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Nov 4, 2014·0 cites·24 claims
- 3347US10010555B2Animal and human anti-trypanosomonal and anti-leishmania agentsCELGENE CORP·Filed 2017·Granted Jul 3, 2018·0 cites·23 claims
- 3447US8598202B2Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolaseAPODACA RICHARD·Filed 2009·Granted Dec 3, 2013·0 cites·36 claims
- 3545US2009062294A1Heteroaryl-substituted urea modulators of fatty acid amide hydrolaseAPODACA RICHARD·Filed 2008·Application pending·0 cites
- 3631US2012225097A1Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah)HAWRYLUK NATALIE A·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →